Abstract It is generally held that inhibition of mammalian sterile 20-like kinase 1 (Mst1) protects the heart through reducing myocyte apoptosis. We determined whether inhibition with a dominant-negative Mst1 (DN-Mst1) would protect against the cardiomyopathy induced by chronic b 1 -adrenergic receptor (b 1 -AR) stimulation by preventing myocyte apoptosis. DN-Mst1 mice were mated with b 1 -AR transgenic (Tg) mice and followed for 20 months. b 1 -AR Tg mice developed cardiomyopathy as they aged, as reflected by premature mortality and depressed cardiac function, which were rescued in b 1 -AR 9 DN-Mst1 bigenic mice. Surprisingly, myocyte apoptosis did not significantly decrease with Mst1 inhibition. Instead, Mst1 inhibition predominantly reduced non-myocyte apoptosis, e.g., fibroblasts, macrophages, neutrophils and endothelial cells. Fibrosis in the hearts with cardiomyopathy increased fivefold and this increase was nearly abolished in the bigenic mice with Mst1 inhibition. Regression analysis showed no correlation between myocyte apoptosis and cardiac function or myocyte number, whereas the latter two correlated significantly, p \ 0.05, with fibrosis, which generally results from necrosis. To examine the role of myocyte necrosis, chronic b-AR stimulation with isoproterenol was induced for 24 h and myocyte necrosis was assessed by 1 % Evans blue dye. Compared to WT, DN-Mst1 mice showed significant inhibition, p \ 0.05, of myocyte necrosis. We confirmed this result in Mst1-knockout mice, which also showed significant protection, p \ 0.05, against myocyte necrosis compared to WT. These data indicate that Mst1 inhibition rescued cardiac fibrosis and myocardial dysfunction in b 1 -AR cardiomyopathy. However, this did not occur through Mst1 inhibition of myocyte apoptosis but rather by inhibition of cardiomyocyte necrosis and non-myocyte apoptosis, features of Mst1 not considered previously.
Introduction
Mammalian sterile 20-like kinase 1 (Mst1) is a serine/ threonine kinase of the Hippo signaling pathway, with regulating apoptosis as one of its major functions [4, 11, 12, 25] . Prior studies in the heart concluded that Mst1 induces cardiac damage through activating myocyte apoptosis and that inhibiting Mst1 is cardioprotective by reducing myocyte apoptosis [5, 6, 27, 31, 45] . The tacit assumption is that Mst1 regulates cardiomyocyte numbers, thereby affecting cardiac function, but this has rarely been measured. To investigate this concept, we examined the extent to which the cardiomyopathy induced by chronic b 1 -adrenergic receptor (b 1 -AR) signaling in b 1 -AR transgenic (Tg) mice [8] was rescued by mating them with dominantnegative Mst1 mice (DN-Mst1) [45] . Our first goal was to determine whether the rescue should occur through reducing apoptosis of myocytes. Given that 75 % of the cells in the heart are non-myocytes [17] , we discriminated the effects of the cardiomyopathy and its rescue with DNMst1 on myocyte vs. non-myocyte apoptosis. The finding that apoptosis predominantly occurred in non-myocytes and DN-Mst1 predominantly rescued non-myocyte apoptosis, supports the hypothesis that DN-Mst1 protects against necrosis, since non-myocytes, e.g., fibroblasts, macrophages, neutrophils, endothelial cells [33, 34, 36, 40] , are all known to be involved in inflammation [9, 18, 39] , which is more closely coupled to necrosis, rather than apoptosis [7, 10, 20, 22, 29, 38] . In further support of the role of necrosis, we also found that myocardial fibrosis, which is generally thought to be an outcome of necrosis rather than apoptosis [3, 10] , was also rescued in the bigenic mice. Finally, we examined whether Mst1 inhibition could prevent necrotic myocyte death. To accomplish this, we subjected DN-Mst1 mice, as well as Mst1-knockout (Mst1-KO) mice to chronic isoproterenol (ISO) challenge and assessed necrotic myocyte injury by in vivo labeling with Evans blue dye (EBD).
Materials and methods

Animals
The development and characterization of mice with cardiac-specific overexpression of b 1 -AR and DN-Mst1 have been described previously [8, 45] . b 1 -AR Tg mice were a generous gift from Dr. Stefan Engelhardt from the University of Wüerzburg. b 1 -AR Tg mice were backcrossed to B6SJL background for seven generations and the resulting mice were mated with DN-Mst1 mice (C57BL6 background) to generate WT, DN-Mst1 Tg, b 1 -AR Tg and b 1 -AR x DN-Mst1 bigenic mice (B6SJL-C57BL6 mixed background). In studies involving old mice, age-matched WT, DN-Mst1 Tg, b 1 -AR Tg and b 1 -AR 9 DN-Mst1 bigenic littermates, with an average age of 18-20 months were used. Mst1-knockout (Mst1-KO) mice (C57BL6-129Sv) [47] were a generous gift from Dr. Joseph Avruch from Harvard Medical School. Animals used in this study were maintained in accordance with the Guide for the Care and Use of Laboratory Animals (National Research Council, 8th Edition 2011). All animal care and protocols were reviewed and approved by the Institutional Animal Care and Use Committee of Rutgers-New Jersey Medical School, Newark, New Jersey, USA.
Measurement of cardiac function
Two-dimensional echocardiography was performed in mice using ultrasonography (Accuson 256, Siemens Medical Solutions) with a 13-MHz linear ultrasound transducer. Left ventricular end-diastolic diameter (LVEDD), LV endsystolic diameter (LVESD), LV fractional shortening (FS), and LV ejection fraction (EF) and LV anterior and posterior wall thickness in systole (LVAWs, LVPWs, respectively) were measured. Cardiac catheterization was performed using a Millar micromanometer in the LV to measure LV systolic pressure (LVSP) and LV end-diastolic pressure (LVEDP). LV systolic wall stress (kdyn/cm 2 ) was calculated as: (1.35 9 LVSP 9 LVESD)/[4 9 LVPWs 9 (1 ? LVPWs/LVESD)].
Detection of apoptosis
Tissue samples were fixed with 10 % neutral buffered formalin and embedded in paraffin. Apoptosis was detected by TUNEL assay (Roche). To discriminate apoptosis in myocytes and non-myocytes, tissue sections (5 lm thickness) were co-stained with rhodamine-conjugated wheat germ agglutinin (WGA) (Vector Laboratories) or Troponin I (TnI, Thermo Scientific), a myocyte marker, as previously described [33, 34] . Nuclei were visualized by ProLong Gold antifade reagent with DAPI (Invitrogen). Apoptotic rate was expressed as the percentage of TUNEL positive cells of interest per myocyte or non-myocyte nuclei. Myocyte apoptosis was also confirmed by western blot analysis measuring cleaved caspase-3 level in isolated cardiomyocytes.
Detection of fibrosis
To examine collagen deposition, LV sections were stained with Masson's trichrome or picrosirius red (PSR). The percentage of fibrosis in LV sections stained with PSR was manually quantified on ImagePro-Plus software.
Detection of myocyte necrosis induced by chronic ISO challenge
Isoproterenol (Sigma-Aldrich) was subcutaneously delivered to WT, DN-Mst1 and Mst1-KO mice (average age of 6 months) by mini-osmotic pumps (ALZET model 2001, DURECT Corp, Cupertino, CA, USA) at a dose of 60 mg/ kg/day as described [23] for 24 h. Immediately after pump implantation, WT, DN-Mst1 and Mst1-KO mice were injected with 1 % Evans blue dye (EBD) via tail-vein at a dose of 100 mg/kg [28] . After 24 h, animals were killed. LV was mounted in Tissue-Tek OCT compound (Sakura, Torrance, CA, USA) and frozen in isopentane pre-cooled in liquid nitrogen. Cryostat sections (10 lm thickness) were counterstained with WGA Alexa Fluor 488 conjugate (Invitrogen) and EBD positive myocytes were quantified. Necrotic myocytes were presented as percentage of EBD positive myocytes per myocyte nuclei.
Detection of inflammatory cells
Left ventricular sections were stained with hematoxylin and eosin (H&E) to visualize infiltrating inflammatory cells.
Calculation of myocyte number
The total number of LV myocytes was measured by the modified method of Olivetti et al. [32] , as reported previously [34] .
Isolation of neonatal rat cardiomyocytes and cell culture Primary cultures of neonatal rat cardiomyocytes were prepared from 1-day-old Wistar rats. Briefly, ventricular myocytes were enzymatically dissociated and pre-plated for 1 h to enrich for myocytes. Cells were plated onto gelatin-coated culture dishes and cultured in DMEM supplemented with 5 % horse serum. Culture medium was changed to serum-free media after 24 h. The cells were further cultured under serum-free conditions for 24 h and then treated with the b-AR agonist, ISO (50 lM).
Isolation of adult cardiac myocytes
Adult cardiomyocytes were isolated from Langendorffperfused mouse hearts as previously described [16] . Briefly, hearts were perfused with enzyme solution containing 1 mg/ml collagenase (type II; Worthington), 0.1 mg/ml protease (type XIV; Sigma) and 10 lM blebbistatin (Toronto Research Chemicals) followed by washing. Digested hearts were removed from the apparatus, placed in a culture dish and mechanically disrupted to release free myocytes. Ca 2? was gradually added to a final concentration of 1.0 mM.
Mst1 kinase assay
Left ventricular tissue homogenates were incubated overnight with anti-Mst1/2 antibody and followed by Protein G-Sepharose (Amersham Biosciences) for an additional 2 h to precipitate endogenous Mst1. After washing, the beads were incubated with [c-32P]ATP (PerkinElmer) and 5 mg substrate myelin basic protein (MBP) in 29 kinase assay buffer [40 mM Hepes/NaOH pH 7.4, 20 mM MgCl2, 1 mM DTT (dithiothreitol), 1 mM ATP, 1 mM sodium orthovanadate, 50 mM sodium fluoride and complete protease inhibitor (Roche)] at 30°C for 20 min. The reaction was terminated by the addition of 0.5 volumes of 3 9 Laemmli sample buffer. The samples were incubated at 95°C for 5 min., resolved on SDS/PAGE (12 % gels) and analyzed by autoradiography.
Matrix metallopeptidase 2 (MMP-2) activity assay
Matrix metallopeptidase 2 activity was measured in LV homogenates using MMP-2 Biotrak Activity Assay (GE Healthcare Life Sciences).
Cellular subfractionation and western blot analysis
Cell fractions from cardiac tissue homogenates were separated by sequential centrifugations at 4°C, including: 5009g for 5 min (nuclei), 30,0009g for 10 min in the presence of 0.25 M sucrose/15 mM NaCl (mitochondria), 100,0009g for 90 min (plasma membrane). The final supernatant contained the cytosolic fraction. Protein extracts were denatured in sample loading buffer by boiling, resolved on 4-20 % SDS/PAGE, and transferred onto nitrocellulose membrane. Immunoblotting was performed using antibodies to Mst1, NFjB, IL-1 from Cell Signaling. Immunodetection was visualized by chemiluminescence (ECL) kit (Amersham Biosciences) and protein expression was quantified by densitometry.
Statistical analysis
All data were expressed as mean ± SEM. To compare two independent groups, we used Student's unpaired t test. For comparisons among three or more groups, one-way ANOVA with Holm Sidak post hoc test was used. Survival analysis was performed by the Kaplan-Meier survival analysis, log rank test. For correlation studies, linear regression analysis was performed, examining the slopes of the relationship and the statistical significance of the correlations. p \ 0.05 was taken as a minimal level of significance for all statistical tests.
Results
Mst1 inhibition rescues b 1 -AR cardiomyopathy
Compared to WT, b 1 -AR Tg mice had significantly increased b 1 -AR protein levels in the heart, which was maintained in the bigenic mice. However, the increased cardiac Mst1 activity in b 1 -AR Tg mice was absent in the bigenic mice (Fig. 1a, b) . We followed the mice for 20 months and assessed their survival by Kaplan-Meier analysis. Whereas b 1 -AR Tg mice showed premature mortality beginning at the age of 13 months, the bigenic mice showed a marked improvement in survival, p \ 0.05, which was no longer different from that in WT mice (Fig. 1c) . The b 1 -AR Tg mice developed cardiomyopathy as they aged, as reflected by increased myocardial fibrosis (Fig. 3b) , increased lung/body weight ratio (5.9 ± 0.5 vs. 4.8 ± 0.2, p \ 0.05) and LV weight/body weight ratio (3.8 ± 0.3 vs. 3.3 ± 0.1, p \ 0.05) without a difference in body weight. Additionally, cardiac function was reduced: compared to old WT, age-matched b 1 -AR Tg mice showed reduced LV ejection fraction (Fig. 1d) , decreased LV fractional shortening and LV wall thickness, and increased and heart rate ( Table 1) . In old bigenics, LV ejection fraction (Fig. 1d) , LV fractional shortening, and LV wall thickness were all rescued (Table 1) . No differences were observed between old DN-Mst1 and age-matched WT. LV wall stress was not different in WT and DN-Mst1 (60 ± 6 vs. 54 ± 4 kdyn/cm 2 ), but doubled, p \ 0.05, in b 1 -AR Tg (115 ± 20 kdyn/cm 2 ) and was rescued in old bigenics (51 ± 4 kdyn/cm 2 ).
Mst1 inhibition does not protect against myocyte apoptosis
Total apoptotic cells in the heart increased almost twofold in old b 1 -AR Tg mice compared to age-matched WT, and were rescued in the bigenic mice. The goal of this study was to examine myocyte-specific apoptosis and non-myocyte apoptosis. Co-staining with TnI or WGA to distinguish myocytes from non-myocytes (Fig. 2b) revealed that 95 % of the increase in apoptosis occurred in non-myocytes (Fig. 2a) ; whereas, myocyte apoptosis comprised only 5 % of the increase in total apoptosis. Conversely, the rescue of apoptosis in the bigenic mice was comprised of 98 % of non-myocytes and only 2 % of myocytes. In fact, the increase in myocyte apoptosis in b 1 -AR Tg mice (0.017 ± 0.004 %) was not significantly reduced in the bigenic mice (0.013 ± 0.004 %). In support of this finding, isolated myocytes from bigenic and b 1 -AR Tg hearts showed no difference in cleaved caspase-3 levels (Fig. 2c,  d ). We examined apoptosis in young mice (3-4 months old) and found similar results to old mice; myocyte apoptosis ranged from 0.003 to 0.009 %, with no significant differences among the groups in young mice.
Mst1 inhibition reduces myocardial fibrosis
Left ventricular sections stained with Masson's trichrome or PSR revealed a fivefold increase in myocardial fibrosis in old b 1 -AR Tg mice compared to WT (19.7 ± 2.3 vs. 3.7 ± 0.2 %, p \ 0.01) (Fig. 3a, b) , which was alleviated, but not abolished, in old bigenic mice (7.4 ± 0.8 %, p \ 0.01).
Correlations
To further clarify the role of myocyte apoptosis and fibrosis in the rescue of cardiomyopathy, we correlated these two parameters individually with each other and with LV ejection fraction. There was absolutely no correlation between myocyte apoptosis and fibrosis (p = 0.56) (Fig. 4a) nor between myocyte apoptosis and LV ejection fraction (p = 0.26) (Fig. 4b) . Conversely, fibrosis correlated significantly with both non-myocyte apoptosis (p = 0.003) (Fig. 4d) and LV ejection fraction (p = 0.03) (Fig. 4e) . Since the hypothesis that inhibiting Mst1 would protect the development of cardiomyopathy through reducing myocyte apoptosis is predicated on its efficacy in preserving contractile units in the heart, it was considered important to correlate myocyte apoptosis and fibrosis with total myocyte numbers in the heart. There was no correlation between myocyte apoptosis and total myocyte number (p = 0.43) (Fig. 4c) ; whereas fibrosis showed strong correlation with total myocyte number (p \ 0.001) (Fig. 4f) . These data suggest that Mst1 inhibition preserves Fig. 4 Linear regression analysis. a-c There is no significant correlation between myocyte apoptosis (%) and either fibrosis (%), LV ejection fraction (LVEF) (%), or total LV myocyte number. df Fibrosis was significantly correlated with non-myocyte apoptosis (%), LVEF (%), and total LV myocyte number myocyte contractile units not by preventing myocyte apoptosis, but rather by inhibiting fibrosis.
Mst1 inhibition reduces myocardial necrosis
Since fibrosis is the aftermath of necrosis, rather than apoptosis [3, 10] , we examined the frequency of necrotic myocytes in young DN-Mst1 and WT mice after 24 h of chronic ISO challenge, which increases Mst1 activation in vitro (Fig. 5a) . In vivo labeling with 1 % EBD, which fluoresces red after binding to albumin [28] , revealed massive necrotic myocyte death in WT hearts, while DNMst1 mice showed minimal necrotic injury (0.88 ± 0.14 vs. 0.32 ± 0.09 %, p \ 0.05) (Fig. 5b, c) . Apoptotic myocytes were also examined by TUNEL, which showed ninefold less positivity in comparison to necrotic myocytes in the WT. Moreover, there was no discernible difference in myocyte apoptosis between WT and DN-Mst1 mice (0.09 ± 0.03 vs. 0.08 ± 0.01 %). To further confirm these results, Mst1 knockout (Mst1-KO) mice were subjected to 24 h of chronic ISO. Mst1-KO mice, like the DN-Mst1 mice, showed significant reduction in necrotic myocytes (0.31 ± 0.11 %, p \ 0.05), while having no significant effect on myocyte apoptosis (Fig. 5c ).
Inhibition of Mst1 reduces pro-inflammatory responses
Given the significant rescue of non-myocyte apoptosis in the bigenic mice and the fact that non-myocytes are comprised of fibroblasts, macrophages, neutrophils and endothelial cells [33, 34, 36, 40] , which are involved in inflammatory processes following necrotic death [7, 10, 20, 22, 29, 38] , we examined whether Mst1 inhibition attenuates pro-inflammatory mechanisms in b 1 -AR Tg mice. LV sections stained with H&E revealed greater inflammatory cell infiltration in b 1 -AR mice, while the bigenic mice only showed a modest increase (Fig. 6a) . Furthermore, the proinflammatory cytokine, IL-1, was significantly elevated in b 1 -AR Tg hearts compared to WT, but drastically reduced in the bigenic hearts (Fig. 6b) . We examined matrix metalloproteinase-2 (MMP-2), a proteolytic enzyme that is intimately involved in extracellular remodeling as well as inflammatory responses, and found significantly increased activity in b 1 -AR Tg hearts compared to WT, but significantly attenuated in the bigenic hearts (Fig. 6c) . Moreover, activation of inflammatory transcription factor nuclear factor jB (NFjB), which has been implicated in the transcriptional regulation of several MMPs, was drastically reduced in the bigenic mice compared to b 1 -AR mice, as reflected by decreased NFjB levels in the nucleus (Fig. 6d) .
Discussion
Although this study demonstrated for the first time that inhibition of Mst1 rescued the cardiomyopathy induced by chronic b-AR stimulation, the major finding of this investigation was that inhibition of Mst1 protects against nonmyocyte apoptosis and myocyte necrosis, rather than myocyte apoptosis, suggesting a new mechanistic role for Mst1. As noted above, the b 1 -adrenergically induced cardiomyopathy was characterized by increased premature mortality, reduced cardiac function and increased myocardial fibrosis. The decrease in LV function with the development of cardiomyopathy was most likely underestimated, since the mice that died early likely had the most severe heart failure. Mating these mice with DN-Mst1 mice prevented the development of b 1 -AR cardiomyopathy; the bigenic mice showed significant decreases in mortality and cardiac fibrosis and preservation of cardiac function compared to b 1 -AR mice. However, in view of Mst1's important role in mediating apoptosis [4, 11, 12, 25] , prior studies concluded that the deleterious or protective effects of Mst1 activation or inhibition was due to its regulation of myocyte apoptosis [5, 6, 27, 31, 45] . Their underlying concept was that inhibition of Mst1 protects apoptosis, which in turn, reduces myocyte loss and consequently maintains the number of contractile units in the heart. This concept is entirely dependent on demonstrating that the apoptosis and its protection occurred in myocytes. Accordingly, we tested this hypothesis. Unlike prior studies on Mst1, we found that the rescue of apoptosis in the bigenic mice predominantly occurred in non-myocytes, while having no significant effects on myocytes. Even though non-myocyte apoptosis is generally unrecognized and has not been reported in prior studies of Mst1 [5, 6, 27, 31, 45] , it is of importance, since 75 % of cells in the heart are non-myocytes [17] . We then correlated the myocyte apoptosis with LV function, and with cardiac fibrosis and found no correlation (Fig. 4a,  b) , suggesting that myocyte apoptosis was not important for the development of the cardiomyopathy or its prevention with DN-Mst1. Since the cardioprotection conferred by Mst1 inhibition is rooted on the concept of preserving myocyte numbers by reducing myocyte apoptosis, we then examined the correlation between myocyte apoptosis and total myocyte numbers. Again, we found no correlation (Fig. 4c) . In contrast, we found a strong correlation between non-myocyte apoptosis and fibrosis (Fig. 4d) , which can be related to Mst1 regulation of non-myocyte apoptosis, since non-myocytes play an important role in formation of fibrosis [13, 14, 21, 24, 46] , which in turn primarily results from necrosis [3, 10] . Therefore, our results differ from all the prior studies concluding that regulation of myocyte apoptosis is the mechanism behind the cardioprotective effects of DN-Mst1 and provide the novel concept that Mst1 regulates myocardial necrosis.
It is well recognized that chronic b-AR stimulation either with isoproterenol [19, 30, 41, 43, 44] or in transgenic models of chronic b-AR stimulation [8, 35] , or in almost all models of heart failure of almost any etiology, which are also characterized by increased b-AR stimulation, involves development of cardiac necrosis [15, 19, 30, 41, 43] , which in turn leads to myocardial fibrosis [3, 10] ; an effect not generally considered an end result from apoptosis. Since we found that development of the b 1 -AR Tg cardiomyopathy was characterized by significantly increased myocardial fibrosis, that was no longer observed in the bigenic mice as they aged, we surmised that the mechanism of the b 1 -AR Tg cardiomyopathy involves to a significant extent myocardial necrosis, and that its rescue by the DN-Mst1 involved protection against myocyte necrosis. In vivo labeling with Evans blue dye showed significant necrotic myocyte death in WT mice after 24 h of chronic ISO; whereas DN-Mst1 and Mst1-KO mice showed strong resistance to necrotic injury, while having no effect on myocyte apoptosis. Our conclusion that the protection against necrosis by Mst1 inhibition is also supported by the finding that DN-Mst1 significantly reduced pro-inflammatory processes, which are linked more closely to necrosis than apoptosis [7, 10, 20, 22, 29, 38] . This concept coupled with the findings of non-myocyte apoptosis in cells that are known to be involved in inflammation, e.g., fibroblasts, macrophages, neutrophils, and endothelial cells [33, 34, 36, 40] , support the conclusion that Mst1 mediates necrosis. A characteristic feature of necrosis is the release of several factors, which not only attract macrophages but also initiate the release of proinflammatory cytokines [2, 38, 42] . Increases in proinflammatory cytokines were demonstrated in this study by the elevated expression level of cytokine IL-1 as well as increases in MMP-2 and NFjB activity in b 1 -AR Tg hearts and their significant decrease in bigenic hearts. This may be one mechanism by which Mst1 inhibition in cardiomyocytes mediates the reduction of non-myocyte apoptosis, i.e., crosstalk between cardiomyocytes and nonmyocytes. It has been shown that serum of patients with congestive heart failure induces endothelial cell apoptosis in vitro [1, 37] and the pro-apoptotic activity was due to pro-inflammatory cytokines released from cardiomyocytes during stress [26, 37] . In the present study, we found significant elevation of pro-inflammatory cytokine, IL-1, in b 1 -AR cardiomyopathy, but a decrease in IL-1 levels as well as reduced non-myocyte apoptosis in animals with cardiac-specific inhibition of Mst1, supporting this crosstalk mechanism.
Therefore, although Mst1 does regulate apoptosis in the heart, it predominantly regulates non-myocyte apoptosis, rather than myocyte apoptosis. The major finding of the present study is that inhibiting Mst1 rescued b 1 -AR cardiomyopathy not through protection of myocyte apoptosis, as would have been predicted from the literature, but rather by reducing myocyte necrosis and non-myocyte apoptosis. These data indicate that Mst1 has a novel role in mediating cellular death in the heart, not previously recognized.
